Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
about
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT).Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMTIndications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects.Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood anLong-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell TransplantationLong-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission.
P2860
Q35641272-9322EF4E-5145-4432-822C-3150E7B0E366Q36121885-7FD6A132-D5AE-4164-A9BB-004B4256645DQ38387292-535F7DFE-9A3B-4FEE-ABBC-180CDD32E04EQ38568355-03091F11-11AD-40AD-B2CF-806E1612799FQ39351385-B05C51EF-6F77-473B-B0C4-83C94F8B8D22Q40831363-EC2DED9A-43A9-48CA-9B0C-1A6990BFA555Q41092916-1B72560A-0CC4-414A-9F9D-18AA303FF539Q42711146-31F10AB6-04B2-4073-9299-D127F19B0612Q45254762-ECA597B9-6542-4470-9DB3-40D0613028B6
P2860
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intravenous busulfan for autol ...... od and Marrow Transplantation.
@ast
Intravenous busulfan for autol ...... od and Marrow Transplantation.
@en
type
label
Intravenous busulfan for autol ...... od and Marrow Transplantation.
@ast
Intravenous busulfan for autol ...... od and Marrow Transplantation.
@en
prefLabel
Intravenous busulfan for autol ...... od and Marrow Transplantation.
@ast
Intravenous busulfan for autol ...... od and Marrow Transplantation.
@en
P2093
P2860
P1433
P1476
Intravenous busulfan for autol ...... ood and Marrow Transplantation
@en
P2093
Aida Botelho Sousa
Angelo M Carella
Antonio Torres Gomez
Arnon Nagler
Avichai Shimoni
Felicetto Ferrara
Giuseppe Irrera
Jose E Guimaraes
Mohamad Mohty
P2860
P304
P356
10.3324/HAEMATOL.2014.105197
P577
2014-05-09T00:00:00Z